{
  "docId": "019de070-cb6f-702e-8ba7-38c2ee57750d",
  "docSlug": "70846fe5de6d20355c3868d80f4845b0",
  "documentTitle": "BioNTech | Results Presentation Deck | 36 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 36,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "key_takeaways",
  "function": "summarize",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "Includes citations for clinical trial data.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-cb6f-702e-8ba7-38c2ee57750d/11",
  "deckHref": "/decks/019de070-cb6f-702e-8ba7-38c2ee57750d",
  "deckJsonHref": "/decks/019de070-cb6f-702e-8ba7-38c2ee57750d.json",
  "deckAnchorHref": "/decks/019de070-cb6f-702e-8ba7-38c2ee57750d#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.18,
        "w": 0.34,
        "x": 0.08,
        "y": 0.29
      },
      "kind": "image",
      "text": "Clinical profile",
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "010f3702-2469-483e-bc70-d73e4989f5da",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.51,
        "w": 0.45,
        "x": 0.5,
        "y": 0.29
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1afec76b-3184-4764-90a7-50eea3508047",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.4,
        "x": 0.06,
        "y": 0.52
      },
      "kind": "list",
      "text": "95% effective against symptomatic COVID-19 infections; 94% efficacy in participants >65 years; Well tolerated safety profile; High titers of neutralizing antibodies; Robust and poly-epitopic CD8+ and Th1 CD4+ T-cell responses",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "5917b55d-182e-4a55-b986-089a89ae18e2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.1,
        "y": 0.94
      },
      "kind": "source-note",
      "text": "1Polack FP, et al. NEJM 2020, 383:2603-2615; 2Sahin U, et al. preprint 2020 (https://www.medrxiv.org/content/10.1101/2020.12.09.20245175v1)",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3ca25c2e-f281-42ca-a5ec-837690262e53",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.3,
        "x": 0.04,
        "y": 0.09
      },
      "kind": "title",
      "text": "Strong clinical results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6ce20294-a15a-4580-8466-778322916443",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 12,
      "from": 9,
      "beatId": "0d035895-f7e2-45cb-b0e1-3c6a1e7c7f66",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Roadmap",
      "beatSlug": null,
      "evidence": "The document outlines BioNTech's plans for the future",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 9,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "0bcbd0a2-69fc-491b-bbac-ee6aab13f39e",
      "evidence": "The document outlines BioNTech's plans to fully exploit and industrialize the potential of its mRNA technology",
      "position": 1,
      "objective": "Explain why BioNTech is well-positioned to address the pandemic",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}